Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie's Disease

H Larson, J Warner, J Savage, T Kohler, M Ziegelmann… - Urology, 2024 - Elsevier
OBJECTIVE To determine change in the point of maximal curvature (POMC) during
Collagenase Clostridium histolyticum (CCH) injections for Peyronie's disease (PD) …

An illustrated description of a modified collagenase Clostridium histolyticum protocol for Peyronie's disease

L Trost - The Journal of Sexual Medicine, 2024 - academic.oup.com
Background Our team recently published outcomes of a novel technique for the
administration of Collagenase Clostridium histolyticum (CCH), which resulted in improved …

Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial

B Green, A Flores, J Warner, T Kohler, S Helo… - The Journal of …, 2023 - auajournals.org
Purpose: Since Food and Drug Administration approval of collagenase Clostridium
histolyticum for Peyronie's disease, there has been significant debate regarding its role and …